Eric A. Adams's most recent trade in InMed Pharmaceuticals Inc was a trade of 6,250 Employee Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Dec. 20, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| InMed Pharmaceuticals Inc | A. Eric Adams | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Dec 2024 | 6,250 | 14,300 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharmaceuticals Inc | Eric A. Adams | Director, President & CEO | 27 May 2024 | 1,139 | 161,000 | - | - | Employee Stock Option (Expiration) | ||
| InMed Pharmaceuticals Inc | Eric A. Adams | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.36 per share. | 20 Feb 2024 | 41,600 | 43,959 | - | 0.4 | 14,922 | Common Stock |
| InMed Pharmaceuticals Inc | A. Eric Adams | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Dec 2023 | 136,000 | 162,139 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharmaceuticals Inc | Eric A. Adams | Director, President & CEO | 16 May 2023 | 1,818 | 26,139 | - | - | Employee Stock Option (Expiration) | ||
| InMed Pharmaceuticals Inc | Eric A. Adams | Director, President & CEO | 08 Mar 2023 | 545 | 27,957 | - | - | Employee Stock Option (Expiration) | ||
| InMed Pharmaceuticals Inc | Eric A. Adams | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2022 | 15,000 | 28,502 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharmaceuticals Inc | Eric A. Adams | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Nov 2022 | 15,000 | 28,502 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharmaceuticals Inc | Eric A. Adams | Director, President & CEO | 02 Jun 2022 | 13,636 | 337,576 | - | - | Employee Stock Option (Expiration) | ||
| InMed Pharmaceuticals Inc | Eric A. Adams | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.89 per share. | 14 Apr 2022 | 14,160 | 59,003 | - | 0.9 | 12,659 | Common Stock |
| InMed Pharmaceuticals Inc | Eric A. Adams | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 0.85 per share. | 13 Apr 2022 | 8,560 | 44,843 | - | 0.9 | 7,276 | Common Stock |
| InMed Pharmaceuticals Inc | Eric A. Adams | Director, President & CEO | 24 Jan 2022 | 60,606 | 411,818 | - | - | Employee Stock Option (Expiration) | ||
| InMed Pharmaceuticals Inc | Eric A. Adams | Director, President & CEO | 24 Jan 2022 | 60,606 | 351,212 | - | - | Employee Stock Option (Expiration) | ||
| InMed Pharmaceuticals Inc | Eric A. Adams | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Oct 2021 | 125,000 | 472,424 | - | - | Employee Stock Option (Right to Buy) | |
| InMed Pharmaceuticals Inc | Eric A. Adams | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 1.73 per share. | 29 Sep 2021 | 8,800 | 36,283 | - | 1.7 | 15,224 | Common Stock |
| InMed Pharmaceuticals Inc | Eric A. Adams | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 1.75 per share. | 28 Sep 2021 | 11,400 | 27,483 | - | 1.8 | 19,984 | Common Stock |
| InMed Pharmaceuticals Inc | Eric A. Adams | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Dec 2020 | 125,000 | 125,000 | - | - | Employee Stock Option (Right to Buy) |